Abbot, S., Bossingham, D., Proudman, S., de Costa, C., & Ho-Huynh, A. (2018). Risk factors for the development of systemic sclerosis: A systematic review of the literature. Rheumatology Advances in Practice, 2(2), rky041. https://doi.org/10.1093/rap/rky041
Fallahi, P., Ruffilli, I., Giuggioli, D., Colaci, M., Ferrari, S. M., Antonelli, A., & Ferri, C. (2017). Associations between Systemic Sclerosis and Thyroid Diseases. Frontiers in Endocrinology, 8, 266. https://doi.org/10.3389/fendo.2017.00266
Lescoat, A., Cavalin, C., Ballerie, A., Lecureur, V., Sesé, L., Cazalets, C., Lederlin, M., Coiffier, G., Belhomme, N., Paris, C., Garlantézec, R., Jouneau, S., & Jégo, P. (2020). Silica Exposure and Scleroderma: More Bridges and Collaboration between Disciplines Are Needed. American Journal of Respiratory and Critical Care Medicine, 201(7), 880–882. https://doi.org/10.1164/rccm.201911-2218LE
Pagkopoulou, E., Arvanitaki, A., Daoussis, D., Garyfallos, A., Kitas, G., & Dimitroulas, T. (2019). Comorbidity burden in systemic sclerosis: Beyond disease-specific complications. Rheumatology International, 39(9), 1507–1517. https://doi.org/10.1007/s00296-019-04371-z
Scleroderma Risk Factors. (n.d.). Retrieved July 9, 2021, from https://www.hopkinsmedicine.org/health/conditions-and-diseases/scleroderma/scleroderma-risk-factors
What is scleroderma? – Scleroderma Foundation. (n.d.). Https://Www.Scleroderma.Org/Site/SPageServer/?Pagename=patients_whatis#.YOiIJpNKiqB. Retrieved July 9, 2021, from https://www.scleroderma.org/site/SPageServer/?pagename=patients_whatis#.YOiIJpNKiqB